CN Stock MarketDetailed Quotes

301201 Chengda Pharmaceuticals

Watchlist

21.30
-0.85-3.84%

Market Closed May 9 15:00 CST

3.30BMarket Cap-68.49P/E (TTM)

Chengda Pharmaceuticals Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q3)Mar 31, 2025

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

Assets

Current assets

Money funds

-62.96%445.5M

-86.92%178.46M

-66.09%479.13M

-33.38%942.4M

-14.87%1.2B

125.66%1.36B

219.75%1.41B

180.73%1.41B

90.52%1.41B

3,168.44%604.43M

Transactional financial assets

540.97%645.13M

--957.65M

--704.97M

--308.78M

--100.65M

----

--776.89M

Notes receivable and accounts receivable

19.06%129.85M

-23.95%94.97M

12.87%73.25M

46.03%104.41M

19.36%109.06M

13.39%124.87M

-26.55%64.89M

-20.61%71.5M

-5.47%91.37M

23.33%110.13M

-Notes receivable

-94.95%20.77K

16.51%291.27K

-40.60%1.69M

-3.03%3.78M

-87.23%411.2K

-89.67%250K

--2.84M

3,151.00%3.9M

648.56%3.22M

1,916.67%2.42M

-Accounts receivable

19.49%129.83M

-24.03%94.68M

15.32%71.56M

48.86%100.63M

23.25%108.65M

15.70%124.62M

-29.76%62.05M

-24.84%67.6M

-8.39%88.16M

20.78%107.71M

Other receivables (including interest and dividends)

21.24%631.83K

-4.08%520.03K

-23.12%474.98K

296.87%336.23K

-38.27%521.13K

14.33%542.16K

-33.48%617.82K

-75.95%84.72K

-6.74%844.15K

-2.39%474.2K

-Other receivable

----

296.87%336.23K

----

14.33%542.16K

----

-75.95%84.72K

----

-2.39%474.2K

Contractual assets

--1.01M

----

Advance payment

-32.54%18.96M

49.90%3.46M

231.84%52.89M

286.15%30.57M

55.18%28.11M

-59.15%2.31M

-27.24%15.94M

-20.39%7.92M

167.25%18.11M

8.94%5.65M

Inventories

9.91%127.03M

3.68%135.27M

-22.13%128.37M

-29.53%117.46M

-18.07%115.58M

-16.59%130.47M

-5.14%164.86M

29.06%166.68M

14.32%141.08M

50.15%156.43M

Receivable financing

----

-2.05%1.77M

----

80.89%1.81M

----

-73.52%1M

Other current assets

245.26%41.04M

122.16%42.05M

3.85%24.13M

-44.68%14.09M

-40.65%11.89M

-23.59%18.93M

44.95%23.24M

247.65%25.48M

6,385.13%20.03M

449.06%24.77M

Total current assets

-10.17%1.41B

-13.86%1.42B

-13.04%1.46B

-9.98%1.52B

-6.87%1.57B

-2.20%1.64B

-3.90%1.68B

-3.07%1.69B

-4.82%1.68B

643.48%1.68B

Non Current assets

Other equity investment

-75.30%7.41M

0.00%30M

--30M

Investment real estate

-2.41%46.26M

-2.40%46.54M

-3.93%46.83M

59.34%47.11M

59.35%47.4M

59.36%47.68M

61.94%48.74M

--29.57M

--29.75M

--29.92M

Fixed assets

----

24.96%458.34M

----

27.98%467.04M

----

12.04%366.8M

----

10.08%364.92M

Constru in process

----

9.76%199.29M

----

16.71%179.17M

----

40.90%181.57M

----

117.16%153.53M

Intangible assets

7.60%36.13M

7.87%36.51M

-3.17%33.04M

-2.23%33.31M

-2.16%33.58M

-2.10%33.85M

-13.32%34.12M

-14.03%34.07M

-13.33%34.32M

-13.19%34.58M

Long deferred expense

0.30%40.65M

1.41%44.12M

267.49%35.75M

251.52%37.93M

241.79%40.53M

236.58%43.5M

-30.47%9.73M

-18.69%10.79M

-18.74%11.86M

99.87%12.93M

Deferred tax assets

98.94%8.38M

87.73%8.06M

13.22%3.88M

-4.66%3.75M

12.32%4.21M

1.58%4.29M

30.80%3.42M

224.12%3.93M

34.59%3.75M

51.74%4.23M

Other non current assets

-68.41%13.94M

-7.40%6.4M

107.80%75.76M

195.66%79.07M

-21.40%44.14M

-42.51%6.91M

143.93%36.46M

330.54%26.74M

292.27%56.16M

100.30%12.03M

Total non current assets

17.40%980.29M

25.70%1.02B

31.50%932.18M

30.04%888.79M

24.37%835.03M

26.53%812.46M

31.67%708.9M

32.31%683.47M

36.75%671.43M

40.42%642.12M

Total assets

-0.59%2.39B

-0.77%2.44B

0.16%2.4B

1.57%2.41B

2.03%2.4B

5.75%2.46B

4.46%2.39B

5.03%2.37B

4.21%2.36B

239.84%2.32B

Liabilities

Current liabilities

Short term loan

----

--600K

--2.67M

----

Notes payable and accounts payable

6.64%138.35M

35.27%189.23M

41.62%146.39M

25.06%133.95M

35.46%129.73M

79.76%139.89M

71.29%103.37M

101.78%107.11M

68.31%95.77M

34.56%77.82M

-Notes payable

-0.07%15.24M

-26.81%23.27M

-34.43%22.93M

15.74%19.04M

399.64%15.26M

--31.79M

--34.97M

580.93%16.45M

26.38%3.05M

----

-Accounts payable

7.53%123.1M

53.53%165.96M

80.50%123.46M

26.75%114.91M

23.47%114.48M

38.91%108.1M

13.35%68.4M

78.93%90.66M

70.17%92.72M

34.56%77.82M

Contract liabilities

-73.79%2.83M

-76.53%2.79M

-79.73%4.83M

184.67%13.89M

-6.13%10.8M

92.01%11.87M

266.64%23.82M

-43.85%4.88M

4.71%11.5M

-20.96%6.18M

Advance receipts

148.53%110.11K

-94.25%16.28K

--101.57K

--103.06K

--44.3K

822.66%283.18K

----

--30.69K

Salaries payable

190.83%7.13M

-1.75%5.03M

32.87%1.13M

230.66%2.54M

216.11%2.45M

41.01%5.12M

-25.45%852.73K

2.72%768.68K

7.33%775.96K

31.62%3.63M

Taxs payable

-80.25%464.63K

-46.51%4.77M

-91.29%447.56K

-230.24%-2.24M

35.24%2.35M

71.76%8.91M

-38.69%5.14M

-83.79%1.72M

-69.16%1.74M

-24.95%5.19M

Other payable (including interest and dividends)

12.05%4.33M

15.38%4.67M

17.08%4.84M

-87.67%4.05M

-8.71%3.87M

-19.30%4.05M

-18.43%4.13M

830.11%32.82M

23.57%4.24M

54.28%5.02M

-Dividend payable

----

--29.01M

----

-Other payable

----

6.18%4.05M

----

-19.30%4.05M

----

8.04%3.81M

----

54.28%5.02M

Non current liabilities due within one year

----

--62.31K

----

Other current liabilities

----

-86.20%194.14K

----

--1.41M

-15.43%1.41M

----

1,059.29%1.66M

Total current liabilities

-0.07%153.22M

20.54%206.76M

14.88%157.74M

3.80%152.9M

34.47%153.32M

72.33%171.53M

68.62%137.31M

92.11%147.3M

46.79%114.02M

-32.65%99.54M

Current liabilities

Long term loan

--88.2M

--80.12M

----

Deferred tax liabilities

0.39%1.36M

-4.37%1.38M

25.72%1.93M

12.29%1.82M

-20.92%1.36M

-20.10%1.44M

-42.98%1.54M

20.45%1.62M

--1.71M

--1.8M

Long term deferred income

-27.03%2.31M

-26.80%2.51M

-26.59%2.71M

-26.42%2.91M

-24.78%3.17M

-23.34%3.43M

-22.05%3.69M

-19.50%3.95M

-19.86%4.21M

-18.92%4.47M

Total non current liabilities

1,930.22%91.87M

1,624.83%84.01M

-11.21%4.64M

-15.16%4.73M

-23.67%4.53M

-22.41%4.87M

-29.64%5.23M

-10.90%5.57M

12.75%5.93M

13.74%6.28M

Total liabilities

55.27%245.09M

64.83%290.77M

13.92%162.38M

3.11%157.62M

31.59%157.85M

66.71%176.4M

60.40%142.54M

84.34%152.88M

44.63%119.95M

-30.98%105.81M

Shareholders equity

Paid-in capital

0.00%154.71M

60.00%154.71M

0.00%96.7M

33.33%96.7M

Capital reserve funds

0.03%1.69B

0.04%1.69B

-3.27%1.69B

0.04%1.75B

1,047.40%1.75B

Surplus reserve funds

4.62%58.49M

19.26%55.91M

29.29%46.88M

Retained profit

-20.68%310.78M

-16.35%312.18M

8.75%383.26M

24.26%398.36M

15.28%391.83M

16.53%373.19M

11.38%352.42M

10.75%320.59M

15.56%339.89M

19.54%320.24M

Less:Treasury stock

9.90%57.07M

--57.07M

--55.28M

--51.93M

--0

----

Other composite income

---19.2M

----

Shareholders equity without minority interests

-4.56%2.14B

-5.89%2.14B

-0.73%2.23B

1.46%2.25B

0.44%2.24B

2.83%2.28B

2.15%2.25B

1.95%2.22B

2.62%2.23B

318.41%2.21B

Minority interests

44.16%2.71M

46.96%2.64M

31.36%2.32M

5.30%1.83M

13.81%1.88M

7.26%1.8M

182.12%1.77M

167.38%1.74M

147.73%1.65M

145.24%1.68M

Total shareholder equity

-4.52%2.14B

-5.85%2.15B

-0.71%2.23B

1.46%2.25B

0.45%2.25B

2.84%2.28B

2.20%2.25B

2.00%2.22B

2.67%2.24B

318.19%2.22B

Total liabilityies and equity

-0.59%2.39B

-0.77%2.44B

0.16%2.4B

1.57%2.41B

2.03%2.4B

5.75%2.46B

4.46%2.39B

5.03%2.37B

4.21%2.36B

239.84%2.32B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Zhonghua Certified Public Accountants (Special General Partnership)

	(Q3)Mar 31, 2025	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022
Assets
Current assets
Money funds	-62.96%445.5M	-86.92%178.46M	-66.09%479.13M	-33.38%942.4M	-14.87%1.2B	125.66%1.36B	219.75%1.41B	180.73%1.41B	90.52%1.41B	3,168.44%604.43M
Transactional financial assets	540.97%645.13M	--957.65M	--704.97M	--308.78M	--100.65M	----	----	----	----	--776.89M
Notes receivable and accounts receivable	19.06%129.85M	-23.95%94.97M	12.87%73.25M	46.03%104.41M	19.36%109.06M	13.39%124.87M	-26.55%64.89M	-20.61%71.5M	-5.47%91.37M	23.33%110.13M
-Notes receivable	-94.95%20.77K	16.51%291.27K	-40.60%1.69M	-3.03%3.78M	-87.23%411.2K	-89.67%250K	--2.84M	3,151.00%3.9M	648.56%3.22M	1,916.67%2.42M
-Accounts receivable	19.49%129.83M	-24.03%94.68M	15.32%71.56M	48.86%100.63M	23.25%108.65M	15.70%124.62M	-29.76%62.05M	-24.84%67.6M	-8.39%88.16M	20.78%107.71M
Other receivables (including interest and dividends)	21.24%631.83K	-4.08%520.03K	-23.12%474.98K	296.87%336.23K	-38.27%521.13K	14.33%542.16K	-33.48%617.82K	-75.95%84.72K	-6.74%844.15K	-2.39%474.2K
-Other receivable	----	----	----	296.87%336.23K	----	14.33%542.16K	----	-75.95%84.72K	----	-2.39%474.2K
Contractual assets	--1.01M	--1.01M	----	----	----	----	----	----	----	----
Advance payment	-32.54%18.96M	49.90%3.46M	231.84%52.89M	286.15%30.57M	55.18%28.11M	-59.15%2.31M	-27.24%15.94M	-20.39%7.92M	167.25%18.11M	8.94%5.65M
Inventories	9.91%127.03M	3.68%135.27M	-22.13%128.37M	-29.53%117.46M	-18.07%115.58M	-16.59%130.47M	-5.14%164.86M	29.06%166.68M	14.32%141.08M	50.15%156.43M
Receivable financing	----	-2.05%1.77M	----	----	----	80.89%1.81M	----	----	----	-73.52%1M
Other current assets	245.26%41.04M	122.16%42.05M	3.85%24.13M	-44.68%14.09M	-40.65%11.89M	-23.59%18.93M	44.95%23.24M	247.65%25.48M	6,385.13%20.03M	449.06%24.77M
Total current assets	-10.17%1.41B	-13.86%1.42B	-13.04%1.46B	-9.98%1.52B	-6.87%1.57B	-2.20%1.64B	-3.90%1.68B	-3.07%1.69B	-4.82%1.68B	643.48%1.68B
Non Current assets
Other equity investment	-75.30%7.41M	-75.30%7.41M	0.00%30M	0.00%30M	0.00%30M	0.00%30M	--30M	--30M	--30M	--30M
Investment real estate	-2.41%46.26M	-2.40%46.54M	-3.93%46.83M	59.34%47.11M	59.35%47.4M	59.36%47.68M	61.94%48.74M	--29.57M	--29.75M	--29.92M
Fixed assets	----	----	----	24.96%458.34M	----	27.98%467.04M	----	12.04%366.8M	----	10.08%364.92M
Constru in process	----	----	----	9.76%199.29M	----	16.71%179.17M	----	40.90%181.57M	----	117.16%153.53M
Intangible assets	7.60%36.13M	7.87%36.51M	-3.17%33.04M	-2.23%33.31M	-2.16%33.58M	-2.10%33.85M	-13.32%34.12M	-14.03%34.07M	-13.33%34.32M	-13.19%34.58M
Long deferred expense	0.30%40.65M	1.41%44.12M	267.49%35.75M	251.52%37.93M	241.79%40.53M	236.58%43.5M	-30.47%9.73M	-18.69%10.79M	-18.74%11.86M	99.87%12.93M
Deferred tax assets	98.94%8.38M	87.73%8.06M	13.22%3.88M	-4.66%3.75M	12.32%4.21M	1.58%4.29M	30.80%3.42M	224.12%3.93M	34.59%3.75M	51.74%4.23M
Other non current assets	-68.41%13.94M	-7.40%6.4M	107.80%75.76M	195.66%79.07M	-21.40%44.14M	-42.51%6.91M	143.93%36.46M	330.54%26.74M	292.27%56.16M	100.30%12.03M
Total non current assets	17.40%980.29M	25.70%1.02B	31.50%932.18M	30.04%888.79M	24.37%835.03M	26.53%812.46M	31.67%708.9M	32.31%683.47M	36.75%671.43M	40.42%642.12M
Total assets	-0.59%2.39B	-0.77%2.44B	0.16%2.4B	1.57%2.41B	2.03%2.4B	5.75%2.46B	4.46%2.39B	5.03%2.37B	4.21%2.36B	239.84%2.32B
Liabilities
Current liabilities
Short term loan	----	----	----	--600K	--2.67M	----	----	----	----	----
Notes payable and accounts payable	6.64%138.35M	35.27%189.23M	41.62%146.39M	25.06%133.95M	35.46%129.73M	79.76%139.89M	71.29%103.37M	101.78%107.11M	68.31%95.77M	34.56%77.82M
-Notes payable	-0.07%15.24M	-26.81%23.27M	-34.43%22.93M	15.74%19.04M	399.64%15.26M	--31.79M	--34.97M	580.93%16.45M	26.38%3.05M	----
-Accounts payable	7.53%123.1M	53.53%165.96M	80.50%123.46M	26.75%114.91M	23.47%114.48M	38.91%108.1M	13.35%68.4M	78.93%90.66M	70.17%92.72M	34.56%77.82M
Contract liabilities	-73.79%2.83M	-76.53%2.79M	-79.73%4.83M	184.67%13.89M	-6.13%10.8M	92.01%11.87M	266.64%23.82M	-43.85%4.88M	4.71%11.5M	-20.96%6.18M
Advance receipts	148.53%110.11K	-94.25%16.28K	--101.57K	--103.06K	--44.3K	822.66%283.18K	----	----	----	--30.69K
Salaries payable	190.83%7.13M	-1.75%5.03M	32.87%1.13M	230.66%2.54M	216.11%2.45M	41.01%5.12M	-25.45%852.73K	2.72%768.68K	7.33%775.96K	31.62%3.63M
Taxs payable	-80.25%464.63K	-46.51%4.77M	-91.29%447.56K	-230.24%-2.24M	35.24%2.35M	71.76%8.91M	-38.69%5.14M	-83.79%1.72M	-69.16%1.74M	-24.95%5.19M
Other payable (including interest and dividends)	12.05%4.33M	15.38%4.67M	17.08%4.84M	-87.67%4.05M	-8.71%3.87M	-19.30%4.05M	-18.43%4.13M	830.11%32.82M	23.57%4.24M	54.28%5.02M
-Dividend payable	----	----	----	----	----	----	----	--29.01M	----	----
-Other payable	----	----	----	6.18%4.05M	----	-19.30%4.05M	----	8.04%3.81M	----	54.28%5.02M
Non current liabilities due within one year	----	--62.31K	----	----	----	----	----	----	----	----
Other current liabilities	----	-86.20%194.14K	----	----	--1.41M	-15.43%1.41M	----	----	----	1,059.29%1.66M
Total current liabilities	-0.07%153.22M	20.54%206.76M	14.88%157.74M	3.80%152.9M	34.47%153.32M	72.33%171.53M	68.62%137.31M	92.11%147.3M	46.79%114.02M	-32.65%99.54M
Current liabilities
Long term loan	--88.2M	--80.12M	----	----	----	----	----	----	----	----
Deferred tax liabilities	0.39%1.36M	-4.37%1.38M	25.72%1.93M	12.29%1.82M	-20.92%1.36M	-20.10%1.44M	-42.98%1.54M	20.45%1.62M	--1.71M	--1.8M
Long term deferred income	-27.03%2.31M	-26.80%2.51M	-26.59%2.71M	-26.42%2.91M	-24.78%3.17M	-23.34%3.43M	-22.05%3.69M	-19.50%3.95M	-19.86%4.21M	-18.92%4.47M
Total non current liabilities	1,930.22%91.87M	1,624.83%84.01M	-11.21%4.64M	-15.16%4.73M	-23.67%4.53M	-22.41%4.87M	-29.64%5.23M	-10.90%5.57M	12.75%5.93M	13.74%6.28M
Total liabilities	55.27%245.09M	64.83%290.77M	13.92%162.38M	3.11%157.62M	31.59%157.85M	66.71%176.4M	60.40%142.54M	84.34%152.88M	44.63%119.95M	-30.98%105.81M
Shareholders equity
Paid-in capital	0.00%154.71M	0.00%154.71M	0.00%154.71M	60.00%154.71M	60.00%154.71M	60.00%154.71M	60.00%154.71M	0.00%96.7M	0.00%96.7M	33.33%96.7M
Capital reserve funds	0.03%1.69B	0.04%1.69B	0.04%1.69B	-3.27%1.69B	-3.27%1.69B	-3.27%1.69B	-3.27%1.69B	0.04%1.75B	0.04%1.75B	1,047.40%1.75B
Surplus reserve funds	4.62%58.49M	4.62%58.49M	19.26%55.91M	19.26%55.91M	19.26%55.91M	19.26%55.91M	29.29%46.88M	29.29%46.88M	29.29%46.88M	29.29%46.88M
Retained profit	-20.68%310.78M	-16.35%312.18M	8.75%383.26M	24.26%398.36M	15.28%391.83M	16.53%373.19M	11.38%352.42M	10.75%320.59M	15.56%339.89M	19.54%320.24M
Less:Treasury stock	9.90%57.07M	--57.07M	--57.07M	--55.28M	--51.93M	--0	----	----	----	----
Other composite income	---19.2M	---19.2M	----	----	----	----	----	----	----	----
Shareholders equity without minority interests	-4.56%2.14B	-5.89%2.14B	-0.73%2.23B	1.46%2.25B	0.44%2.24B	2.83%2.28B	2.15%2.25B	1.95%2.22B	2.62%2.23B	318.41%2.21B
Minority interests	44.16%2.71M	46.96%2.64M	31.36%2.32M	5.30%1.83M	13.81%1.88M	7.26%1.8M	182.12%1.77M	167.38%1.74M	147.73%1.65M	145.24%1.68M
Total shareholder equity	-4.52%2.14B	-5.85%2.15B	-0.71%2.23B	1.46%2.25B	0.45%2.25B	2.84%2.28B	2.20%2.25B	2.00%2.22B	2.67%2.24B	318.19%2.22B
Total liabilityies and equity	-0.59%2.39B	-0.77%2.44B	0.16%2.4B	1.57%2.41B	2.03%2.4B	5.75%2.46B	4.46%2.39B	5.03%2.37B	4.21%2.36B	239.84%2.32B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion
Auditor	--	Zhonghua Certified Public Accountants (Special General Partnership)	--	--	--	Zhonghua Certified Public Accountants (Special General Partnership)	--	--	--	Zhonghua Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

301201 Chengda Pharmaceuticals

Chengda Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Market Insights

Discussing

Latest News

Investment Course